CN113045390A - Method for preparing triclosan by Baeyer-Villiger oxidation - Google Patents

Method for preparing triclosan by Baeyer-Villiger oxidation Download PDF

Info

Publication number
CN113045390A
CN113045390A CN202110287411.3A CN202110287411A CN113045390A CN 113045390 A CN113045390 A CN 113045390A CN 202110287411 A CN202110287411 A CN 202110287411A CN 113045390 A CN113045390 A CN 113045390A
Authority
CN
China
Prior art keywords
chloro
acid
acetophenone
phenoxy
inert solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110287411.3A
Other languages
Chinese (zh)
Inventor
张奉志
杨修东
陈善任
徐欣
葛均官
郭鹏
张美堂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zaozhuang Runan Pharmaceutical New Material Co ltd
Original Assignee
Zaozhuang Runan Pharmaceutical New Material Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaozhuang Runan Pharmaceutical New Material Co ltd filed Critical Zaozhuang Runan Pharmaceutical New Material Co ltd
Priority to CN202110287411.3A priority Critical patent/CN113045390A/en
Publication of CN113045390A publication Critical patent/CN113045390A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/39Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester
    • C07C67/42Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester by oxidation of secondary alcohols or ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a method for preparing dichlorohydrin by using carbamide peroxide as an oxidant, which comprises the following steps: (1) oxidizing 5-chloro-2- (4-chloro-phenoxy) -acetophenone in an inert solvent with carbamide peroxide as an oxidizing agent to obtain an intermediate I; (2) and hydrolyzing the intermediate I to obtain the dichloro-raw material. The method has safe production process and mild reaction, and is suitable for industrial production.

Description

Method for preparing triclosan by Baeyer-Villiger oxidation
Technical Field
The invention belongs to the field of chemical synthesis, and particularly provides a preparation method of triclosan.
Background
Dichloro-raw, chemical name is 5-chloro-2- (4-chlorophenoxy) -phenol, is an active bactericide with wide application, and can be used as a bactericidal component in coatings, paints, adhesives, detergents and surface cleaners. It can effectively inhibit 23 kinds of bacteria such as gram-positive bacteria, gram-negative bacteria, bacteria and mould.
At present, the synthesis method of dichlorohenzene mainly uses p-dichlorobenzene as raw material, and the dichlorohenzene is obtained by Friedel-crafts, substitution, oxidation and hydrolysis. Among them, Baeyer-Villiger oxidation is a key step, and is also studied more. Armando et al (WO 0183418A1) use m-chloroperoxybenzoic acid as an oxidant, which is not only more costly, but also has a lower reaction yield (39%). The oxidant used by Lourens et al (WO 9910310A1) is hydrogen peroxide, but the concentration requirement is high (49.2-62.5%), and the reaction risk is high. The method is improved by Jonjt et al (university of east China school of Industrial science, 2007, 33, 75-78), the concentration of hydrogen peroxide is reduced to 30%, but the reaction process releases heat severely, and the solvent cannot be recovered, so that the requirement of mass production cannot be met.
In conclusion, the field lacks a method for preparing the dichloro-raw material, which has safe production process and mild reaction and is suitable for industrial production.
Disclosure of Invention
The invention aims to provide a method for preparing dichlorohydrin, which has safe production process and mild reaction and is suitable for industrial production.
The invention provides a method for preparing dichlorohydrin by adopting carbamide peroxide as an oxidant. Carbamide peroxide (UHP) is a complex resulting from strong hydrogen bonding between urea and hydrogen peroxide. It converts unstable hydrogen peroxide into solid which is easy to operate, safe and stable at room temperature, and has low price. UHP shows different oxidation capacities under different solvents and catalysts, is an important oxidation reagent in organic synthesis, is successfully applied to the synthesis of the dichlorohydrin, and has advantages in cost and safety compared with the existing synthesis method.
In a first aspect of the present invention, there is provided a process for the preparation of triclosan, the process comprising the steps of:
(1) oxidizing 5-chloro-2- (4-chloro-phenoxy) -acetophenone with an oxidizing agent in an inert solvent to obtain an intermediate I;
(2) hydrolyzing the intermediate I to obtain dichloro raw;
Figure BDA0002981069510000021
in another preferred embodiment, in the step (1), the oxidant is selected from the group consisting of: sodium persulfate, m-CPBA, UHP, or combinations thereof.
In another preferred embodiment, said step (1) is carried out under acid or base catalysis, and said acid is selected from the group consisting of: concentrated sulfuric acid, concentrated hydrochloric acid, acetic acid, trifluoroacetic acid, or a combination thereof; the alkali is NaHCO3
In another preferred example, the step (1) is carried out under the catalysis of concentrated sulfuric acid.
In another preferred embodiment, the molar ratio of the 5-chloro-2- (4-chloro-phenoxy) -acetophenone to the oxidant is 1: 2-5.
In another preferred embodiment, the molar ratio of the 5-chloro-2- (4-chloro-phenoxy) -acetophenone to the oxidant is 1: 3-4.
In another preferred embodiment, the molar ratio of the 5-chloro-2- (4-chloro-phenoxy) -acetophenone to the acid is 10-30: 1.
In another preferred embodiment, the molar ratio of the 5-chloro-2- (4-chloro-phenoxy) -acetophenone to the acid is 15-25: 1.
In another preferred embodiment, the inert solvent is selected from the group consisting of: dichloromethane, acetonitrile, dimethylformamide, or combinations thereof.
In another preferred embodiment, the inert solvent is dichloromethane.
In another preferred embodiment, said step (1) is carried out at 0-40 ℃.
In another preferred embodiment, said step (2) is performed under acidic condition or alkaline condition.
In another preferred embodiment, in the step (2), the acidic condition is provided by a reagent selected from the group consisting of: a mineral acid, a sulfonic acid, a lewis acid, a solid acid, or a combination thereof.
In another preferred embodiment, in the step (2), the alkaline condition is provided by a reagent selected from the group consisting of: alkali metal hydroxides, alkali metal amides, alkali metal alkoxides, alkaline earth metal hydroxides, alkaline earth metal amides, alkaline earth metal alkoxides, and organic bases.
In another preferred embodiment, in the step (2), the acidic condition is provided by an acid selected from the group consisting of: hydrochloric acid, sulfuric acid, trifluoroacetic acid, formic acid, or a combination thereof.
In another preferred embodiment, in the step (2), the alkaline condition is provided by an alkali selected from the group consisting of: sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, or a combination thereof.
In another preferred embodiment, in the step (2), the alkaline condition is provided by adding 20-40 wt% sodium hydroxide solution.
In another preferred embodiment, said step (2) is carried out in an inert solvent.
In another preferred embodiment, the inert solvent is selected from the group consisting of: toluene, benzene, xylene, or combinations thereof.
In another preferred embodiment, said step (2) is carried out at reflux temperature.
In a second aspect of the present invention, there is provided a process for the preparation of a compound of formula I, as shown in the following formula, said process comprising the steps of:
(1) oxidizing 5-chloro-2- (4-chloro-phenoxy) -acetophenone with an oxidizing agent in an inert solvent to obtain an intermediate I;
Figure BDA0002981069510000031
it is to be understood that within the scope of the present invention, the above-described features of the present invention and those specifically described below (e.g., in the examples) may be combined with each other to form new or preferred embodiments. Not to be reiterated herein, but to the extent of space.
Compared with the prior art, the invention has the advantages that:
the invention provides a method for preparing triclosan by Baeyer-Villiger oxidation. Compared with the prior art, the method has the advantages of simple operation, mild reaction conditions, high yield, low cost and recoverable solvent, and is suitable for industrial production.
Detailed Description
The invention will be further illustrated with reference to the following specific examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. The experimental procedures, in which specific conditions are not noted in the following examples, are generally carried out under conventional conditions or conditions recommended by the manufacturers. Unless otherwise indicated, percentages and parts are by weight.
Example 1:
to a 50mL reaction flask were added dichloromethane (25mL), 5-chloro-2- (4-chloro-phenoxy) -acetophenone (2.81g, 10mmol), and concentrated sulfuric acid (0.05g, 0.5mmol) in that order. The temperature was reduced to 0 ℃ with stirring, and urea peroxide (1.88g, 20mmol) was added to the reaction mixture in portions. After the addition was complete, the temperature was raised to room temperature and stirring was continued for 24 h. The solvent was distilled off under reduced pressure, and then toluene (15mL) and 30% sodium hydroxide solution (5mL) were added to the residue, and refluxed for 2 h. And cooling the reaction solution to room temperature, and adjusting the pH value to 2-5 by using a 15% hydrochloric acid solution. Standing, separating, removing the water phase, and washing the organic phase with 10% sodium bicarbonate and water respectively. The solvent was evaporated to dryness under reduced pressure and recrystallized from n-hexane to give dichloro-raw (1.35g, 53%).1H NMR(CDCl3,400MHz)δ5.33(s,1H);6.78(d,1H,J=6.64Hz);6.84(d,1H,J=6.65Hz);6.94(d,2H,J=8.94Hz);7.06(s,1H);7.30(d,2H,J=8.94Hz)。
Example 2:
to a 50mL reaction flask were added dichloromethane (25mL), 5-chloro-2- (4-chloro-phenoxy) -acetophenone (2.81g, 10mmol), and concentrated sulfuric acid (0.05g, 0.5mmol) in that order. The temperature was reduced to 0 ℃ with stirring, and urea peroxide (2.82g, 30mmol) was added to the reaction mixture in portions. After the addition was complete, the temperature was raised to room temperature and stirring was continued for 24 h. The solvent was distilled off under reduced pressure, and then toluene (15mL) and 30% sodium hydroxide solution (5mL) were added to the residue, and refluxed for 2 h. Dichlorobenzene (1.58g, 62%) was obtained by the workup of example 1.
Example 3:
to a 50mL reaction flask were added dimethylformamide (25mL), 5-chloro-2- (4-chloro-phenoxy) -acetophenone (2.81g, 10mmol), and concentrated sulfuric acid (0.05g, 0.5mmol) in that order. The temperature was reduced to 0 ℃ with stirring, and urea peroxide (2.82g, 30mmol) was added to the reaction mixture in portions. After the addition was complete, the temperature was raised to room temperature and stirring was continued for 24 h. Toluene (15mL) and 30% sodium hydroxide solution (5mL) were added to the reaction and refluxed for 2 h. Dichlorobenzene (1.05g, 41%) was obtained by the workup of example 1.
Example 4:
to a 100mL reaction flask were added acetonitrile (50mL), 5-chloro-2- (4-chloro-phenoxy) -acetophenone (5.62g, 20mmol), and concentrated sulfuric acid (0.10g, 1mmol) in that order. The temperature was reduced to 0 ℃ with stirring, and urea peroxide (5.64g, 60mmol) was added to the reaction mixture in portions. After the addition was complete, the temperature was raised to room temperature and stirring was continued for 24 h. The solvent was distilled off under reduced pressure, and then toluene (15mL) and 30% sodium hydroxide solution (5mL) were added to the residue, and refluxed for 2 h. Dichlorobenzene (2.37g, 46%) was obtained by the workup of example 1.
Example 5:
to a 50mL reaction flask were added dichloromethane (25mL), 5-chloro-2- (4-chloro-phenoxy) -acetophenone (2.81g, 10mmol), and trifluoroacetic acid (0.06g, 0.5mmol) in that order. The temperature was reduced to 0 ℃ with stirring, and urea peroxide (2.82g, 30mmol) was added to the reaction mixture in portions. After the addition was complete, the temperature was raised to room temperature and stirring was continued for 24 h. The solvent was distilled off under reduced pressure, and then toluene (15mL) and 30% sodium hydroxide solution (5mL) were added to the residue, and refluxed for 2 h. Dichlorobenzene (0.84g, 33%) was obtained by the workup of example 1.
Comparative example 1:
to a 50mL reaction flask were added dichloromethane (25mL), 5-chloro-2- (4-chloro-phenoxy) -acetophenone (2.81g, 10mmol), and concentrated sulfuric acid (0.05g, 0.5mmol) in that order. The temperature was reduced to 0 ℃ with stirring, and urea peroxide (0.92g, 10mmol) was added to the reaction mixture in portions. After the addition was complete, the temperature was raised to room temperature and stirring was continued for 24 h. The solvent was distilled off under reduced pressure, and then toluene (15mL) and 30% sodium hydroxide solution (5mL) were added to the residue, and refluxed for 2 h. And cooling the reaction solution to room temperature, and adjusting the pH value to 2-5 by using a 15% hydrochloric acid solution. Standing, separating, removing the water phase, and washing the organic phase with 10% sodium bicarbonate and water respectively. The solvent was evaporated to dryness under reduced pressure and recrystallized from n-hexane to yield dichloro-raw (1.18g, 46%).
The results show that the reaction yield is significantly reduced when the amount of carbamide peroxide is reduced.
Example 6:
to a 50mL reaction flask were added dichloromethane (25mL), 5-chloro-2- (4-chloro-phenoxy) -acetophenone (2.81g, 10mmol), and concentrated sulfuric acid (0.05g, 0.5mmol) in that order. The temperature was reduced to 0 ℃ with stirring, and urea peroxide (4.6g, 50mmol) was added to the reaction mixture in portions. After the addition was complete, the temperature was raised to room temperature and stirring was continued for 24 h. The solvent was distilled off under reduced pressure, and then toluene (15mL) and 30% sodium hydroxide solution (5mL) were added to the residue, and refluxed for 2 h. And cooling the reaction solution to room temperature, and adjusting the pH value to 2-5 by using a 15% hydrochloric acid solution. Standing, separating, removing the water phase, and washing the organic phase with 10% sodium bicarbonate and water respectively. The solvent was evaporated to dryness under reduced pressure and recrystallized from n-hexane to yield dichloro-raw (1.23g, 48%).
The results show that with 5 equivalents of carbamide peroxide, a reduction in the reaction yield of the process occurs, probably due to the production of by-products during the oxidation.

Claims (10)

1. A method for preparing triclosan, comprising the steps of:
(1) oxidizing 5-chloro-2- (4-chloro-phenoxy) -acetophenone with an oxidizing agent in an inert solvent to obtain an intermediate I;
(2) hydrolyzing the intermediate I to obtain dichloro raw;
Figure FDA0002981069500000011
2. the method of claim 1, wherein in step (1), the oxidizing agent is selected from the group consisting of: sodium persulfate, m-CPBA, UHP, or combinations thereof.
3. The method of claim 1, wherein step (1) is performed under acid or base catalysis, and the acid is selected from the group consisting of: concentrated sulfuric acid, concentrated hydrochloric acid, acetic acid, trifluoroacetic acid, or a combination thereof; the alkali is NaHCO3
4. The method of claim 1, wherein step (1) is carried out under catalysis of concentrated sulfuric acid.
5. The method of claim 1, wherein the molar ratio of 5-chloro-2- (4-chloro-phenoxy) -acetophenone to carbamide peroxide is 1: 2-5.
6. The method of claim 1, wherein the molar ratio of the 5-chloro-2- (4-chloro-phenoxy) -acetophenone to the acid is 10-30: 1.
7. The method of claim 1, wherein the inert solvent is selected from the group consisting of: dichloromethane, acetonitrile, dimethylformamide, or combinations thereof.
8. The process of claim 1 wherein the inert solvent is methylene chloride.
9. The method of claim 1, wherein step (1) is performed at 0-40 ℃.
10. A process for the preparation of a compound of formula I, comprising the steps of:
(1) oxidizing 5-chloro-2- (4-chloro-phenoxy) -acetophenone in an inert solvent with carbamide peroxide as an oxidizing agent to obtain an intermediate I;
Figure FDA0002981069500000021
CN202110287411.3A 2021-03-17 2021-03-17 Method for preparing triclosan by Baeyer-Villiger oxidation Pending CN113045390A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110287411.3A CN113045390A (en) 2021-03-17 2021-03-17 Method for preparing triclosan by Baeyer-Villiger oxidation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110287411.3A CN113045390A (en) 2021-03-17 2021-03-17 Method for preparing triclosan by Baeyer-Villiger oxidation

Publications (1)

Publication Number Publication Date
CN113045390A true CN113045390A (en) 2021-06-29

Family

ID=76513218

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110287411.3A Pending CN113045390A (en) 2021-03-17 2021-03-17 Method for preparing triclosan by Baeyer-Villiger oxidation

Country Status (1)

Country Link
CN (1) CN113045390A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1320516A1 (en) * 2000-05-04 2003-06-25 Ciba SC Holding AG Process for the preparation of halogenated hydroxydiphenyl compounds
CN101747250A (en) * 2008-12-16 2010-06-23 上海医药工业研究院 Method for preparing 4 - acyloxo heterocyclic ketone compounds
CN103613498A (en) * 2013-11-20 2014-03-05 浙江三门恒康制药有限公司 Synthetic method of ciprofibrate
CN103864601A (en) * 2014-03-20 2014-06-18 广东广益科技实业有限公司 Process for synthesizing milk lactone
CN108261349A (en) * 2018-03-06 2018-07-10 山东美齿汇医疗科技有限公司 Tooth whitening liquid

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1320516A1 (en) * 2000-05-04 2003-06-25 Ciba SC Holding AG Process for the preparation of halogenated hydroxydiphenyl compounds
CN1427811A (en) * 2000-05-04 2003-07-02 西巴特殊化学品控股有限公司 Process for preparation of halogenated hydroxydiphenyl compounds
CN101747250A (en) * 2008-12-16 2010-06-23 上海医药工业研究院 Method for preparing 4 - acyloxo heterocyclic ketone compounds
CN103613498A (en) * 2013-11-20 2014-03-05 浙江三门恒康制药有限公司 Synthetic method of ciprofibrate
CN103864601A (en) * 2014-03-20 2014-06-18 广东广益科技实业有限公司 Process for synthesizing milk lactone
CN108261349A (en) * 2018-03-06 2018-07-10 山东美齿汇医疗科技有限公司 Tooth whitening liquid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
马祥梅: "《新峪炼焦煤中有机硫的赋存及硫醚硫醇类有机硫的微波响应研究》", 30 June 2017, 中国矿业大学出版社 *
黄致喜等: "《现代合成香料》", 31 May 2009, 中国轻工业出版社 *

Similar Documents

Publication Publication Date Title
US7265251B2 (en) Process for the preparation of nitroalkenes
WO2018062563A1 (en) Bisfuran dihalide, method for producing bisfuran dihalide, and method for producing bisfuran diacid, bisfuran diol or bisfuran diamine using bisfuran dihalide
CN110054593A (en) Method for synthesizing 1,3, 5-triazine derivative
CN114181123A (en) Green synthesis method of 6-ethylthio-3 hepten-2-one
CN113045390A (en) Method for preparing triclosan by Baeyer-Villiger oxidation
KR101707237B1 (en) Process for preparing substituted 1,4-quinone methides
CN105013535A (en) Catalyst for preparing asymmetric conjugated dialkyne compound and synthesis method therefor
CN108727161A (en) A kind of method that the efficient one's own department or unit hydroxylating of phenyl boric acid prepares phenol
CN112010793B (en) Synthetic method of 2-methylsulfonyl-4-trifluoromethylbenzoic acid
CN113912500A (en) Method for preparing amine compound by using microchannel reactor
JP4550492B2 (en) Method for producing fluorine-containing acetophenone and use thereof
EP3851429A1 (en) A process for the purification of crisaborole
CN113121799B (en) Application of bis (fluorosulfonyl) imide as catalyst
CN111018807B (en) Method for synthesizing 1,2, 4-thiadiazole derivative
CN1037509C (en) Process for the preparation of ortho-hydroxy substituted aromatic nitriles via dehydration of the corresponding aldoximes
CN114349686A (en) 1, 4-dihydropyridine chiral hybrid hydrogenation reagent and preparation method and application thereof
CN111635287A (en) Synthesis method of substituted phenol
CN104876806A (en) Novel method for synthesizing bisoprolol importance intermediate
KR20030027005A (en) Process for the Preparation of 5-[(4-Chlorophenyl)-methyl]-2,2-dimethylcyclopentanone
JP3269188B2 (en) Method for producing carboxylic acid derivative
El-Hiti Application of organolithium in organic synthesis: a simple and convenient procedure for the synthesis of more complex 6-substituted 3 H-quinazolin-4-ones
CN112358380B (en) Synthesis method of 4- (4' -alkylcyclohexyl) cyclohexanol
JP4979170B2 (en) Process for producing 5-[(4-chlorophenyl) methyl] -2,2-dimethylcyclopentanone
CN115246769B (en) Oxidation method of benzaldehyde derivative
JP2775319B2 (en) Method for producing diarylethylene glycol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 277400 50m north of the intersection of Tanxue road and Huangshan Road, Eshan Town, Yicheng, Zaozhuang City, Shandong Province

Applicant after: ZAOZHUANG RUNAN PHARMACEUTICAL NEW MATERIAL Co.,Ltd.

Address before: 277400 Guangyuan Road, development zone, Taierzhuang District, Zaozhuang City, Shandong Province

Applicant before: ZAOZHUANG RUNAN PHARMACEUTICAL NEW MATERIAL Co.,Ltd.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210629